ACTRN12618001121257	*NOT prior_therapy:Denosumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12618001742268	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
ACTRN12619000844145	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Lorlatinib
ACTRN12620000861954	*NOT prior_therapy:BRAF_inhibitor
ACTRN12621000312842	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:Alectinib
ACTRN12621000811808	*NOT prior_therapy:MET_inhibitor
NCT02408861	*NOT prior_therapy:Nivolumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT02477826	*NOT prior_therapy:systemic_therapy
NCT02568267	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:ROS1_inhibitor
NCT02609776	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Poziotinib; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent; *prior_therapy:Erlotinib; *prior_therapy:Osimertinib
NCT02628067	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT02775435	*NOT prior_therapy:Cetuximab; *NOT prior_therapy:Crizotinib; *NOT prior_therapy:Erlotinib; *NOT prior_therapy:Paclitaxel; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT02974725	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:Trametinib
NCT03157128	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03170960	*NOT prior_therapy:Cabozantinib; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03207867	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:Taxane; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:Cisplatin; *prior_therapy:Oxaliplatin; *prior_therapy:platinum-based_antineoplastic_agent
NCT03212404	*NOT prior_therapy:Ipilimumab; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT03319628	*NOT prior_therapy:Taxane; *prior_therapy:Bevacizumab; *prior_therapy:platinum-based_antineoplastic_agent
NCT03319940	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03358875	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT03454451	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody
NCT03497767	*NOT prior_therapy:Osimertinib; *NOT prior_therapy:immune_checkpoint_blockade
NCT03516981	*NOT prior_therapy:VEGF_inhibitor; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03539536	*NOT prior_therapy:telisotuzumab
NCT03549000	*NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03611868	*NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03708328	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03735121	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT03893955	*NOT prior_therapy:Taxane; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT03948763	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody
NCT03974022	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Poziotinib; *NOT prior_therapy:anti-HER2
NCT03976375	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:Lenvatinib; *NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT03994393	*NOT prior_therapy:Afatinib; *NOT prior_therapy:Tremelimumab; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04000529	*NOT prior_therapy:CDK4/6_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04032704	*prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04129502	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:systemic_therapy
NCT04154956	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04222972	*NOT prior_therapy:Pembrolizumab; *NOT prior_therapy:Taxane; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04242199	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody
NCT04282018	*NOT prior_therapy:PI3K_inhibitor
NCT04294810	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04300244	*NOT prior_therapy:Nivolumab; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT04427072	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:MET_inhibitor
NCT04432207	*NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04434482	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04447118	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT04475939	*NOT prior_therapy:PARP_inhibitor; *NOT prior_therapy:systemic_therapy
NCT04487080	*NOT prior_therapy:systemic_therapy
NCT04513925	*NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:platinum-based_antineoplastic_agent
NCT04524689	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody
NCT04538664	*NOT prior_therapy:Carboplatin
NCT04585815	*NOT prior_therapy:BRAF_inhibitor; *NOT prior_therapy:MEK_inhibitor; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04612751	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Cisplatin; *NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04619004	*NOT prior_therapy:Bevacizumab; *NOT prior_therapy:topoisomerase I inhibitor; *prior_therapy:Osimertinib; *prior_therapy:platinum-based_antineoplastic_agent
NCT04623775	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04624204	*NOT prior_therapy:Olaparib; *NOT prior_therapy:anti-CD137_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:systemic_therapy
NCT04644237	*prior_therapy:platinum-based_antineoplastic_agent
NCT04655976	*NOT prior_therapy:Carboplatin; *NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *prior_therapy:Cisplatin; *prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04656652	*NOT prior_therapy:Docetaxel; *prior_therapy:platinum-based_antineoplastic_agent
NCT04702880	*NOT prior_therapy:systemic_therapy
NCT04721015	*NOT prior_therapy:platinum-based_antineoplastic_agent
NCT04725188	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade
NCT04745689	*NOT prior_therapy:platinum-based_antineoplastic_agent; *NOT prior_therapy:systemic_therapy
NCT04746924	*NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
NCT04844073	*NOT prior_therapy:ALK_inhibitor; *NOT prior_therapy:immune_checkpoint_blockade; *prior_therapy:Oxaliplatin; *prior_therapy:platinum-based_antineoplastic_agent
NCT04849273	*NOT prior_therapy:Alectinib; *NOT prior_therapy:Lorlatinib
NCT04914897	*NOT prior_therapy:Docetaxel; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *prior_therapy:platinum-based_antineoplastic_agent
NCT04921358	*NOT prior_therapy:Docetaxel
NCT05005273	*NOT prior_therapy:systemic_therapy
NCT05014815	*NOT prior_therapy:anti-CTLA-4_monoclonal_antibody; *NOT prior_therapy:anti-PD-1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L1_monoclonal_antibody; *NOT prior_therapy:anti-PD-L2_monoclonal_antibody; *NOT prior_therapy:immune_checkpoint_blockade; *NOT prior_therapy:systemic_therapy
